Clinical Trial Update: A Study of HDM1005 in Participants With T2DM Not Controlled With Metformin Alone or in Combination With a Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating HDM1005 in adults with type 2 diabetes mellitus not adequately controlled with metformin, with or without an SGLT2 inhibitor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• HDM1005

Snippet

Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Conditions: Type 2 Diabetes | Phase 3 | Status: NOT_YET_RECRUITING